Literature DB >> 2628371

Prevention of congenital toxoplasmosis; experience in The Netherlands.

M A Conyn-van Spaendonck1.   

Abstract

Prevention is the pre-eminent strategy to control congenital toxoplasmosis. In a trial study in the province South-Holland a program of both primary and secondary prevention during pregnancy was applied. 28000 women were enrolled. 55% of them were seronegative, and only 55 primary infections were traced amongst them. Although a conclusive evaluation of the results of the study has not yet been accomplished, this low figure will be discussed within the scope of certain logistic and organizational obstacles incurred in the so-called TIP (Toxoplasma Infection Prevention)-study in the Netherlands.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2628371     DOI: 10.1007/bf02306489

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  6 in total

1.  Breaking the transmission chain of Toxoplasma: a program for the prevention of human toxoplasmosis.

Authors:  J K Frenkel
Journal:  Bull N Y Acad Med       Date:  1974-02

2.  Congenital toxoplasmosis. A prospective study of 378 pregnancies.

Authors:  G Desmonts; J Couvreur
Journal:  N Engl J Med       Date:  1974-05-16       Impact factor: 91.245

3.  Results of 20-year follow-up of congenital toxoplasmosis.

Authors:  J G Koppe; D H Loewer-Sieger; H de Roever-Bonnet
Journal:  Lancet       Date:  1986-02-01       Impact factor: 79.321

4.  Prevalence of toxoplasma antibodies according to age with comments on the risk of prenatal infection.

Authors:  J van der Veen; M F Polak
Journal:  J Hyg (Lond)       Date:  1980-10

5.  Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection.

Authors:  C B Wilson; J S Remington; S Stagno; D W Reynolds
Journal:  Pediatrics       Date:  1980-11       Impact factor: 7.124

6.  Impact of primary prevention on the incidence of toxoplasmosis during pregnancy.

Authors:  W Foulon; A Naessens; S Lauwers; F De Meuter; J J Amy
Journal:  Obstet Gynecol       Date:  1988-09       Impact factor: 7.661

  6 in total
  3 in total

Review 1.  Ocular involvement in toxoplasmosis.

Authors:  A Rothova
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

2.  Evaluation of a commercial IgG/IgM Western blot assay for early postnatal diagnosis of congenital toxoplasmosis.

Authors:  V Rilling; K Dietz; D Krczal; F Knotek; G Enders
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-05       Impact factor: 3.267

3.  Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth.

Authors:  R E Gilbert; M R Stanford; H Jackson; R E Holliman; M D Sanders
Journal:  BMJ       Date:  1995-04-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.